ETON PHARMACEUTICALS INC (ETON:NASDAQ)
$44.85 2.54 (6.0033%)
Analysed ETON PHARMACEUTICALS INC (ETON:NASDAQ) News Sources
Eton Pharmaceuticals Q1 Earnings Call Highlights
15-05-2026
marketbeat.com
Eton Pharmaceuticals Inc (ETON) Q1 2026 Earnings Call Highlights: Record Sales and Strategic ...
15-05-2026
yahoo.com
Eton Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
15-05-2026
moby.co
Eton (ETON) Q1 2026 Earnings Call Transcript
15-05-2026
fool.com
Eton Pharmaceuticals, Inc. Just Missed EPS By 44%: Here's What Analysts Think Will Happen Next
16-05-2026
yahoo.com
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
19-05-2026
yahoo.com
Stock Market Leaders Respect The 21-Day Line. You Should Too.
22-05-2026
yahoo.com
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals’ (ETON) Growth Strategy
23-05-2026
yahoo.com
Apple upgraded, Brinker initiated: Wall Street's top analyst calls
17-07-2026
yahoo.com
Eton Pharmaceuticals (ETON) Moves 13.8% Higher: Will This Strength Last?
20-07-2026
yahoo.com
What is the current price of ETON PHARMACEUTICALS INC (ETON:NASDAQ)?
The current price of ETON PHARMACEUTICALS INC (ETON:NASDAQ) is $44.85.
ETON PHARMACEUTICALS INC (ETON:NASDAQ) absolute price change since previous trading day?
The absolute price change of ETON PHARMACEUTICALS INC (ETON:NASDAQ) since the previous trading day is $2.54.
ETON PHARMACEUTICALS INC (ETON:NASDAQ) percentage price change since previous trading day?
The percentage price change of ETON PHARMACEUTICALS INC (ETON:NASDAQ) since the previous trading day is 6.0033%.
What is the most recent average sentiment score for ETON PHARMACEUTICALS INC (ETON:NASDAQ)?
The most recent average sentiment score for ETON PHARMACEUTICALS INC (ETON:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for ETON PHARMACEUTICALS INC (ETON:NASDAQ)?
The most recent sentiment for ETON PHARMACEUTICALS INC (ETON:NASDAQ) is .
SEC-8K** Filing Available For ETON PHARMACEUTICALS INC (ETON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.